Synthesis, stability, and subcellular distribution of major histocompatibility complex class II molecules in Langerhans cells infected with Leishmania major

Infection and Immunity

Volumn 65, Issue 8, 1997, Pages 3444-3450

  Flohé, Stefanie ^a   Lang, Thierry ^b   Moll, Heidrun ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ADOLESCENT; ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; CELL VACUOLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FEMALE; IMMUNOREGULATION; LANGERHANS CELL; LEISHMANIA MAJOR; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN METABOLISM; PROTEIN STABILITY; PROTEIN SYNTHESIS; SKIN LEISHMANIASIS;

EID: 0030878297     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.65.8.3444-3450.1997     Document Type: Article

References (43)

1. Antoine, J.-C., C. Jouanne, T. Lang, E. Prina, C. de Chastellier, and C. Frehel. 1991. Localization of major histocompalibility complex class II molecules in phagolysosomes of murine macrophages infected with Leishmania amazonensis. Infect. Immun. 59:764-775.
2. Becker, D., A. B. Reske-Kunz, J. Knop, and K. Reske. 1991. Biochemical properties of MHC class II molecules endogenously synthesized and expressed by mouse Langerhans cells. Eur. J. Immunol. 21:1213-1220.
3. Bhattacharya, A., M. E. Dorf, and T. A. Springer. 1981. A shared alloantigenic determinant on Ia antigens encoded by the I-A and I-E subrogions: evidence for I region gene duplication. J. Immunol. 127:2488-2495.
4. Blank, C., C. Bogdan, C. Bauer, K. Erb, and H. Moll. 1996. Murine epidermal Langerhans cells do not express inducible nitric oxide synthase. Eur. J. Immunol. 26:792-796.
5. Blank, C., H. Fuchs, K. Rappersberger, M. Röllinghoff, and H. Moll. 1993. Parasitism of epidermal Langerhans cells in experimental cutaneous leishmaniasis with Leishmania major. J. Infect. Dis. 167:418-425.
6. Bogdan, C., H. Moll, W. Solbach, and M. Röllinghoff. 1990. Tumor necrosis factor-α in combination with interferon-γ, but not with interleukin 4, activates murine macrophages for elimination of Leishmania major amastigotes. Eur. J. Immunol. 20:1131-1135.
7. Demotz, S., H. M. Grey, and A. Sette. 1990. The minimal number of class II MHC-antigen complexes needed for T cell activation. Science 249:1028-1030.
8. Germain, R. N., and L. R. Hendrix. 1991. MHC class II structure, occupancy and surface expression determined by post-endoplasmic reticulum antigen binding. Nature 353:134-139.
9. Harding, C. V., and E. R. Unanue. 1990. Quantitation of antigen-presenting cell MHC class II/peptide complexes necessary for T-cell stimulation. Nature 346:574-576.
10. Inaba, K., J. P. Metlay, M. T. Crowley, and R. M. Steinman. 1990. Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T cells in situ. J. Exp. Med. 172:631-640.
11. Kämpgen, E., N. Koch, F. Koch, P. Stöger, C. Heufler, G. Schuler, and N. Romani. 1991. Class II major histocompatibility complex molecules of murine dendritic cells: synthesis, sialylation of invariant chain, and antigen processing capacity are down-regulated upon culture. Proc. Natl. Acad. Sci. USA 88:3014-3018.
12. Kaye, P. M., C. Coburn, M. McCrossan, and S. M. Beverley. 1993. Antigens targeted to the Leishmania phagolysosome are processed for CD4+ T cell recognition. Eur. J. Immunol. 23:2311-2319.
13. Kleijmeer, M. J., V. M. J. Oorschot, and H. J. Geuze. 1994. Human resident Langerhans cells display a lysosomal compartment enriched in MHC class II. J. Invest. Dermatol. 103:516-523.
14. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
15. Lang, T., C. de Chastellier, C. Frehel, R. Hellio, P. Metezeau, S. de Souza Leao, and J.-C. Antoine. 1994. Distribution of MHC class I and of MHC class II molecules in macrophages infected with Leishmania amazonensis. J. Cell Sci. 107:69-82.
16. Lang, T., R. Hellio, P. M. Kaye, and J.-C. Antoine. 1994. Leishmania dono-vani-infected macrophages: characterization of the parasitophorous vacuole and potential role of this organelle in antigen presentation. J. Cell Sci. 107:2137-2150.
17. Lang, T., and P. M. Kaye. 1991. Presentation of Leishmania donovani promastigotes occurs via a brefeldin A-sensitive pathway. Eur. J. Immunol. 21:2407-2413.
18. Lanier, L. L., G. A. Gutman, D. E. Lewis, S. T. Griswold, and N. L. Warner. 1982. Monoclonal antibodies against rat immunuglobulin kappa chains. Hybridoma 1:125-131.
19. Larsen, C. P., S. C. Ritchie, R. Hendrix, P. S. Linsley, K. S. Hathcock, R. J. Hudes, R. P. Lowry, and T. C. Pearson. 1994. Regulation of immunostimulatory function and costimulatory molecule (B7-1 and B7-2) expression on murine dendritic cells. J. Immunol. 152:5208-5219.
20. Larsen, C. P., R. M. Steinman, M. Witmer-Pack, D. F. Hankins, P. J. Morris, and J. M. Austyn. 1990. Migration and maturation of Langerhans cells in skin transplants and explants. J. Exp. Med. 172:1483-1493.
21. Levine, T. P., and B. M. Chain. 1992. Endocytosis by antigen presenting cells: dendritic cells are as endocytically active as other antigen presenting cells. Proc. Natl. Acad. Sci. USA 89:8342-8346.
22. Moll, H. 1993. Experimental cutaneous leishmaniasis: Langerhans cells internalize Leishmania major and induce an antigen-specific T-cell response. Adv. Exp. Med. Biol. 329:587-592.
23. Moll, H., S. Flohé, and C. Blank. 1995. Langerhans cells in cutaneous leishmaniasis, p. 159-175. In H. Moll (ed.), The immune functions of epidermal Langerhans cells. R. G. Landes Company, Austin, Tex.
24. Moll, H., S. Flohé, and M. Röllinghoff. 1995. Dendritic cells in Leishmania major-immune mice harbor persistent parasites and mediate an antigen-specific T cell immune response. Eur. J. Immunol. 25:693-699.
25. Moll, H., H. Fuchs, C. Blank, and M. Röllinghoff. 1993. Langerhans cells transport Leishmania major from the infected skin to the draining lymph node for presentation to antigen-specific T cells. Eur. J. Immunol. 23:1595-1601.
26. Ozato, K., N. Mayer, and D. Sachs. 1980. Hybridoma cell lines secreting monoclonal antibodies to mouse H-2 and Ia antigens. J. Immunol. 124:533-540.
27. Puré, E., K. Inaba, M. T. Crowley, L. Tardelli, M. D. Witmer-Pack, G. Ruberti, G. C. Fathman, and R. M. Steinman. 1990. Antigen processing by epidermal Langerhans cells correlates with the level of biosynthesis of major histocompatibility complex class II molecules and expression of invariant chain. J. Exp. Med. 172:1459-1469.
28. Romani, N., S. Koide, M. Crowley, M. Witmer-Pack, A. M. Livingstone, C. G. Fathman, K. Inaba, and R. M. Steinman. 1989. Presentation of exogenous protein antigens by dendritic cells to T cell clones: intact protein is presented best by immature epidermal Langerhans cells. J. Exp. Med. 169:1169-1178.
29. Sadegh-Nasseri, S., and R. N. Germain. 1992. How MHC class II molecules work: peptide-dependent completion of protein folding. Immunol. Today 13:43-46.
30. Scheicher, C., M. Mehlig, H.-P. Dienes, and K. Reske. 1995. Uptake of microparticle-adsorbed protein antigen by bone marrow-derived dendritic cells results in up-regulation of interleukin-1α and interleukin 12 p40/p35 and triggers prolonged, efficient antigen presentation. Eur. J. Immunol. 25:1566-1572.
31. Schuler, G., and F. Koch. 1990. Enrichment of epidermal Langerhans cells, p. 139-157. In G. Schuler (ed.), Epidermal Langerhans cells. CRC Press, Inc., Boca Raton, Fla.
32. Schuler, G., and R. M. Steinman. 1985. Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro. J. Exp. Med. 161:526-546.
33. Shimada, S., S. W. Caughman, S. O. Sharrow, D. Stephany, and S. I. Katz. 1987. Enhanced antigen-presenting capacity of cultured Langerhans cells is associated with markedly increased expression of Ia antigen. J. Immunol. 139:2551-2556.
34. Solbach, W., K. Forberg, E. Kammerer, C. Bogdan, and M. Röllinghoff. 1986. Suppressive effect of cyclosporin A on the development of Leishmania tropica-induced lesions in genetically susceptible BALB/c mice. J. Immunol. 137:702-707.
35. Steinman, R. M., K. Inaba, and G. Schuler. 1995. Cutaneous dendritic cells: distinctive antigen-presenting cells for experimental models and disease states, p. 1-19. In H. Moll (ed.), The immune functions of epidermal Langerhans cells. R. G. Landes Company, Austin, Tex.
36. Stenger, S., H. Thüring, M. Röllinghoff, and C. Bogdan. 1994. Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania major. J. Exp. Med. 180:783-793.
37. Stössel, H., F. Koch, E. Kämpgen, P. Stöger, A. Lenz, C. Heufler, N. Romani, and G. Schuler. 1990. Disappearance of certain acidic organelles (endosomes and Langerhans cell granules) accompanies loss of antigen processing capacity upon culture of epidermal Langerhans cells. J. Exp. Med. 172:1471-1482.
38. Streilein, J, W., and S. F. Grammer. 1989. In vitro evidence that Langerhans cells can adopt two functionally distinct forms capable of antigen presentation to T lymphocytes. J. Immunol. 143:3925-3933.
39. Tulp, A., D. Verwoerd, B. Dobberstein, H. L. Ploegh, and J. Pieters. 1994. Isolation and characterization of the intracellular MHC class II compartment. Nature 369:120-126.
40. Viola, A., and A. Lanzavecchia. 1996. T cell activation determined by T cell receptor number and tunable thresholds. Science 273:104-106.
41. Wei, X.-Q., I. G. Charles, A. Smith, J. Ure, G.-J. Feng, F.-P. Huang, D. Xu, W. Müller, S. Moncada, and F. Y. Liew. 1995. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 375:408-411.
42. Will, A., C. Blank, M. Röllinghoff, and H. Moll. 1992. Murine epidermal Langerhans cells are potent stimulators of an antigen-specific T cell response to Leishmania major, the cause of cutaneous leishmaniasis. Eur. J. Immunol. 22:1341-1347.
43. Witmer-Pack, M. D., W. Olivier, J. Valinsky, G. Schuler, and R. M. Steinman. 1987. Granulocyte/macrophage colony-stimulating factor is essential for the viability and function of cultured murine epidermal Langerhans cells. J. Exp. Med. 166:1484-1498.